Chronic Pain Relief Shifts Focus to Root Causes and Genetic Screening

Chronic pain management is moving away from a binary choice between enduring discomfort and relying on strong opioids.

Dr. Rhea Rogers, a board-certified physician, argues that effective treatment depends on identifying the specific cause of the pain rather than simply masking symptoms. Rogers states that understanding the root cause opens the door to alternative therapies, including movement and stretching. This approach aims to provide patients with a wider range of non-opioid options for long-term care.

Financial barriers often complicate pain management, as high prescription costs can limit access to necessary medication. Rogers suggests that patients start by discussing their bills directly with doctors or pharmacists. These providers may have access to free prescription drug programs, samples, or discount cards that can reduce out-of-pocket expenses. For those enrolled in Medicare, aging expert Amy O’Rourke advises reviewing Part D coverage annually. She notes that this review can reveal opportunities to lower premiums or switch to more affordable plans.

A free genetic research project in Nebraska is identifying hidden cancer risks in individuals with no known family history of the disease. The study, known as the Genetic Insights Project, operates out of Nebraska Medicine. Participants are tested for mutations such as BRCA2, which are linked to higher cancer risks. The program aims to detect these genetic markers before symptoms appear, allowing for earlier intervention.

Erin Thoman, a nurse practitioner in Nebraska, is one such participant. Thoman’s sister initially took the test and discovered she carried a BRCA2 mutation. Subsequent testing through the same program revealed that Thoman and her mother also carried the mutation. Thoman has since met with a breast surgeon at Nebraska Medicine. She is expected to undergo a double mastectomy, a procedure that would lower her breast cancer risk from approximately 60 percent to less than 10 percent.

Dr. Doug Stoller, a cardiologist involved in the initiative, explains that the primary goal is early detection. Researchers are currently working to enroll up to 100,000 people in Nebraska. The nationwide target for the program is 3 million participants. This scale allows for a larger dataset to identify genetic patterns and improve prevention strategies.

The program includes a disclaimer that it serves educational and informational purposes and does not constitute medical advice. It recommends that individuals consult a licensed physician for personal medical decisions. The initiative is part of a larger effort to integrate genetic insights into routine health planning.

The study is part of a wider trend in healthcare that combines personalized treatment with cost-saving measures. By linking genetic data with practical financial advice, the program addresses both the physical and economic aspects of chronic health conditions. The Nebraska component serves as a pilot for the larger national enrollment drive.